18F ‐ FDG PET / CT for Surveillance in Salivary Gland Cancers: A Systematic Review and Meta‐Analysis
The Laryngoscope · 2025
DOI: 10.1002/lary.32003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Laryngoscope, 2025. Verfasst von Emily Ajit-Roger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Salivary Gland Neoplasms, Fluorodeoxyglucose F18, Neoplasm Recurrence, Local. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the diagnostic accuracy of 18F‐FDG‐PET/CT compared to conventional imaging modalities (CIM) to detect recurrence of primary salivary gland cancers (SGCs). Data Sources Review performed on December 26, 2024, using Embase, CINHAL, MEDLINE, and PubMed. Review Methods Two blinded reviewers selected studies reporting diagnostic accuracy of PET/CT in identifying locoregional recurrence and/or metastasis in patients with SGCs. The analysis was performed adhering to PRISMA guidelines using R 4.3.3. Pooled analysis with 95% confidence intervals (CI) were analyzed.
Results
A total of 12 studies were retained from the systematic review, including 264 patients evaluated in the meta‐analysis. For local recurrence, there was a pooled sensitivity of 0.86 (95% CI 0.73–0.93) and a pooled specificity of 0.95 (95% CI 0.92–0.97) for PET/CT, and a pooled sensitivity of 0.89 (95% CI 0.80–0.94) and a pooled specificity of 0.91 (95% CI 0.79–0.97) for CIM ( p = 0.90). For regional metastasis, there was a pooled sensitivity of 0.90 (95% CI 0.73–0.97) and a pooled specificity of 0.96 (95% CI 0.92–0.98) for PET/CT, and a pooled sensitivity of 0.80 (95% CI 0.62–0.91) and a pooled specificity of 0.95 (0.90–0.98) for CIM ( p = 0.26). For distant metastasis, there was a pooled sensitivity of 0.96 (95% CI 0.90–0.99) and a pooled specificity of 0.95 (95% CI 0.85–0.98) for PET/CT, and a pooled sensitivity of 0.80 (95% CI 0.71–0.86) and a pooled specificity of 0.97 (95% CI 0.87–0.99) for CIM ( p = 0.018).
Conclusions
18F‐FDG‐PET/CT imaging is accurate for the detection of SGC recurrence, particularly for the detection of regional and distant metastases. Level of Evidence NA Laryngoscope , 135:1884–1898, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
- Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Quebec, Canada.
- Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Oncology, McGill University, Montreal, Quebec, Canada.
- Centre for Clinical Epidemiology, Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
ORCID-Profile: Emily Ajit-Roger, Nader Sadeghi
Zitieren
APA
Ajit-Roger, E., Richardson, K., Mlynarek, A. M., Sadeghi, N., Hier, M. P., & Mascarella, M. A. (2025). 18F ‐ FDG PET / CT for Surveillance in Salivary Gland Cancers: A Systematic Review and Meta‐Analysis. The Laryngoscope. https://doi.org/10.1002/lary.32003
Vancouver
Ajit-Roger E, Richardson K, Mlynarek AM, Sadeghi N, Hier MP, Mascarella MA. 18F ‐ FDG PET / CT for Surveillance in Salivary Gland Cancers: A Systematic Review and Meta‐Analysis. The Laryngoscope. 2025. doi:10.1002/lary.32003
BibTeX
@article{AjitRoger2025,
author = {Ajit-Roger, Emily and Richardson, Keith and Mlynarek, Alex Marcin and Sadeghi, Nader and Hier, Michael P and Mascarella, Marco A},
title = {18F ‐ FDG PET / CT for Surveillance in Salivary Gland Cancers: A Systematic Review and Meta‐Analysis},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32003}
}
EUVIMED